Immunological landscape and immunotherapy of hepatocellular carcinoma

J Prieto, I Melero, B Sangro - Nature reviews Gastroenterology & …, 2015 - nature.com
Advanced hepatocellular carcinoma (HCC) is a serious therapeutic challenge and targeted
therapies only provide a modest benefit in terms of overall survival. Novel approaches are …

Toxoplasma gondii: CD8 T Cells Cry for CD4 Help

IA Khan, SJ Hwang, M Moretto - Frontiers in cellular and infection …, 2019 - frontiersin.org
Toxoplasma gondii, an apicomplexan parasite, is a pathogenic protozoan that can infect the
central nervous system. In pregnant women, infection can result in congenital problems of …

Single-cell atlas of the aging mouse colon

D Širvinskas, O Omrani, J Lu, M Rasa, A Krepelova… - Iscience, 2022 - cell.com
We performed massive single-cell sequencing in the aging mouse colonic epithelium and
immune cells. We identified novel compartment-specific markers as well as dramatic aging …

Tumor microenvironment in hepatocellular carcinoma: key players for immunotherapy

H Feng, Y Zhuo, X Zhang, Y Li, Y Li… - Journal of …, 2022 - Taylor & Francis
Hepatocellular carcinoma (HCC) remains a serious medical therapeutic challenge as
conventional curative avenues such as surgery and chemotherapy only benefit for few …

The human immune response to Toxoplasma: Autophagy versus cell death

S Krishnamurthy, EK Konstantinou, LH Young… - PLoS …, 2017 - journals.plos.org
Toxoplasma gondii is an obligate intracellular parasite that can infect a broad range of
warmblooded animals. In humans, it can cause serious disease in immune-compromised …

Simultaneous inhibition of PD-1 and stimulation of CD40 signaling pathways by anti-PD-L1/CD40L bispecific fusion protein synergistically activate target and effector …

MS Pandey, C Wang, S Umlauf, S Lin - International Journal of Molecular …, 2021 - mdpi.com
Bispecific antibodies (BsAbs) or fusion proteins (BsAbFPs) present a promising strategy for
cancer immunotherapy. Numerous BsAbs targeting coinhibitory and costimulatory pathways …

[HTML][HTML] Requirement for CD40/CD40L interactions for development of autoimmunity differs depending on specific checkpoint and costimulatory pathways

E Voynova, T Mahmoud, LT Woods, GA Weisman… - …, 2018 - journals.aai.org
Abstract CD40/CD40L interactions play a critical role in immunity and autoimmunity. In this
study, we sought to understand the requirement for CD40 signaling in the programmed cell …

A genetic variant in the CD40 gene is related to HBV infection in the Chinese Han population

W Wu, S Xu, Y Zeng, L Yu, T Chen… - Hepatology …, 2023 - journals.lww.com
Background: CD40 is an important immune costimulatory molecule that has recently been
found to be associated with chronic hepatitis B. This study aims to explore the association …

Современная лабораторная диагностика и биомаркеры инфекционных болезней

ИП Балмасова - Инфекционные болезни: Новости. Мнения …, 2015 - cyberleninka.ru
Одна из особенностей современных медицинских технологий заключается в
стремлении к экономически оправданным, эффективным, точным и наименее …

Sensitization of tumor cells for T cell mediated eradication through targeted delivery of virus-derived immunogenic peptide epitopes

JP Sefrin - 2017 - archiv.ub.uni-heidelberg.de
The work presented in this thesis aimed at the development of antibody immunoconjugates
for the delivery in tumor cells of highly immunogenic T cell epitopes that mediate the antigen …